Biotech Chimerix Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares January 25, 2021
Biotech DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Fortress Biotech, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm January 25, 2021
Biotech FBIO Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 January 25, 2021
Biotech Atossa Therapeutics President and CEO Dr. Steven C. Quay to Speak at Precision Medicine World Conference, Spotlighting Anthony S. Fauci, MD, Director NIAID January 25-27, 2021 January 25, 2021
Biotech Relief Therapeutics and Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration and License Agreement for the Worldwide Development and Commercialization of ACER-001 for the Treatment of Urea Cycle Disorders and Maple Syrup Urine Disease January 25, 2021
Biotech Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021 January 25, 2021
Biotech Eiger BioPharmaceuticals Announces U.S. Commercial Availability of Zokinvy(TM) (lonafarnib), the First and Only Treatment Approved for Progeria and Processing-Deficient Progeroid Laminopathies January 25, 2021
Search
Biotech
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
January 25, 2021
